The Cochlear (ASX: COH) share price is up 4% this last week

It's been a good recovery week for shares in the hearing device manufacturer.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cochlear Limited (ASX: COH) share price is having a great start to the new month after struggling through a less than ideal August.

Cochlear shares fell 4.97% over the course of last month, with the biggest catalyst for the drop being the company's financial year 2021 earnings.

Fortunately, Cochlear's stock ended August and started September on an upward trajectory. It has gained 4.47% over the course of this week.

Right now, the Cochlear share price is trading at $237.10, gaining 1.96% today alone.

Let's take a look at what's been happening lately.

Medical staff wear hero capes, indicting strong shar [price performace for healthcare shares

Image source: Getty Images

What's up with Cochlear this week?

Shares in the hearing device manufacturer appear to be recovering after a poor month's performance in August.

It has pulled itself up by the bootstraps this week after posting lower than expected profits for the 2021 financial year and less than satisfactory guidance for the financial year 2022.

As The Motley Fool Australia reported at the time, despite the company reporting profits inside its previously given guidance, it fell short of the market's expectations.

The Cochlear share price suffered as a result, falling 7.4% on the day it posted its earnings results. The following week, shares in the company continued their downwards trajectory, falling another 4.3%.

The market hasn't heard any fresh news from Cochlear since. However, investor confidence in the ASX healthcare giant appears to have rebounded and its shares are recovering the lost ground.

Cochlear share price snapshot

The Cochlear share price has performed well on the ASX this year.

Including this week's upturn, it has gained 24% since the start of 2021 and is 20% higher than it was this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A man in a shirt and tie looks to the horizon holding his hand above his eyes as if to shield the sun so he can see better.
Healthcare Shares

Why is everyone talking about 4DX shares this week?

It's all eyes on the healthcare stock this week.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Healthcare Shares

$10,000 invested in this ASX healthcare share a year ago is now worth $36,500

This stock has experienced a dramatic price increase.

Read more »

A male doctor and a woman in scrubs in the foreground smile.
Healthcare Shares

The ASX healthcare stocks with the biggest upside according to brokers

These two healthcare stocks could be value buys.

Read more »

Cropped shot of a young female scientist working on her computer in the laboratory.
Healthcare Shares

Here's one reason why experts think the CSL share price can rise 65%!

There’s more than one reason why experts are excited by the potential of CSL.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Forget DroneShield and EOS, this ASX healthcare stock is up 15x in a year!

There is no doubt that 4DMedical is one of the hottest stocks on the ASX right now.

Read more »

Scientists in white coats look disappointed.
Healthcare Shares

$5,000 invested in CSL shares 12 months ago is now worth…

Are the biotech company's shares worth holding onto?

Read more »

Happy healthcare workers in a lab.
Healthcare Shares

Clarity Pharmaceuticals shares are up 12% today. Here's what's driving the move

Today's announcement moves Clarity a step closer towards commercialisation.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Healthcare Shares

Which ASX biotech's shares are rocketing higher on big US news?

This company has more than doubled in value over the past three months.

Read more »